Lilly
  • Prescribing Information
  • Patient Prescribing Information
Menu closed
Lilly
  • Prescribing Information
  • Patient Prescribing Information
  • For Patients
  • For Healthcare Providers
    • CYRAMZA® (ramucirumab)
    • ERBITUX® (cetuximab)
    • Jaypirca™ (pirtobrutinib)
    • Retevmo® (selpercatinib)
    • Verzenio® (abemaciclib)
    • Support and Resources
  • Contact Us

Jaypirca™ (pirtobrutinib)

Savings and Support

Paying for treatment shouldn’t be an additional concern for your loved ones, so we’ve created savings and support options which may help you manage treatment costs.

Explore the savings and support options available for Jaypirca™ or Please call [insert number] to enroll in the Jaypirca™ Savings Card Program.

Alternate Funding Resources

When insurance isn’t enough to pay for treatment or you have no insurance, there are other funding resources that may help with your financial challenges to get the medication you need.

Lilly Patient Access Resources

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Lilly Cares® Foundation

The Lilly Cares Foundation, Inc., a separate nonprofit organization, offers a patient assistance program to help qualifying patients receive Lilly medications at no cost. For more information about Lilly Cares, please visit LillyCares.com.

Independent Patient-Assistance Program Foundations

The Lilly Oncology Support Center provides information about a number of independent patient-assistance programs that may be able to help underinsured patients get the treatment they need with less financial stress. These foundations are not affiliated with Eli Lilly and Company and are operated independently. Funding availability changes weekly, so contact a Lilly Oncology Support Center representative at 1-866-472-8663 for the most recent updates.

View Foundation List

Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call 1-866-472-8663
Monday - Friday, 8am — 10pm ET

This site is intended for US healthcare professionals only.

PP-OC-US-0369 01/2023 ©Lilly USA, LLC 2023. All rights reserved.

ALIMTA®, CYRAMZA®, ERBITUX®, Retevmo®, and Verzenio® are registered trademarks and Jaypirca™ and Verzenio Continuous Care™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Other product/company names mentioned herein are the property of their respective owners.

Terms of UsePrivacy StatementAccessibility StatementSitemap
Lilly